BiotechTube
Home/Corteria Pharmaceuticals/Francesca C. Lawson
FC

Francesca C. Lawson

CMO

Corteria Pharmaceuticals

Therapeutic Areas

CardiovascularMetabolic DisordersMusculoskeletal

Corteria Pharmaceuticals Pipeline

DrugIndicationPhase
COR-1167Worsening Heart FailurePhase 2
COR-1389Obesity and Right Heart FailurePhase 1
Vasopressin Neutralizing AntibodyHeart Failure (implied)Preclinical

Leadership Team at Corteria Pharmaceuticals

PJ
Philip Janiak
CEO
MO
Marie-Laure Ozoux
CSO
RO
Régis Olivier
CAO
View full Corteria Pharmaceuticals profile